cdmo.directory
← Compare landing

Applied Pharmaceutical Innovation vs CMC Pharmaceuticals, Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/appliedpharma/cmcpharm

CategoryApplied Pharmaceutical InnovationCMC Pharmaceuticals, Inc.
Listed sitebothcdmo
SummaryEdmonton-based not-for-profit offering integrated CDMO services in sterile fill-finish, oral solid dosage, topical application, and highly potent controlled substance manufacturing. Also provides CRO research, regulatory and quality, and clinical and quantitative support.CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.
Services
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Small Molecule Development & Manufacturing
  • Controlled Substance Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Formulation Development
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Controlled Substance Manufacturing
  • HPAPI Manufacturing (High-Potency)
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Edmonton, Alberta, Canada
  • Calgary, Calgary, Alberta, Canada
  • Headquarters, Solon, Ohio, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.